GW PHARMACEUTICALS PLC (GWPH)
Institutional ownership reported to the SEC as of Q2 2024, across 13 quarters.
1
Reporting holders
$8.2K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Strategic Investment Solutions, Inc. /IL | $8.2K | 38 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2024 | 1 | $8.2K | 38 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $24.0K | 109 | 1 | 0 | 0 | 0.0% |
| Q2 2021 | 1 | $3.0K | 30 | 0 | 0 | 0 | 0.0% |
| Q1 2021 | 297 | $5.5B | 24,380,569 | 115 | 33 | 82 | 3.5% |
| Q4 2020 | 275 | $3.1B | 24,545,175 | 32 | 64 | 81 | 8.5% |
| Q3 2020 | 274 | $2.6B | 24,778,689 | 26 | 84 | 59 | 7.7% |
| Q2 2020 | 299 | $3.3B | 25,004,267 | 51 | 59 | 98 | 5.4% |
| Q1 2020 | 285 | $2.5B | 26,213,448 | 36 | 75 | 91 | 6.5% |
| Q4 2019 | 315 | $2.9B | 24,806,798 | 47 | 108 | 72 | 10.9% |
| Q3 2019 | 315 | $3.3B | 24,900,697 | 44 | 97 | 78 | 12.6% |
| Q2 2019 | 328 | $5.0B | 26,193,227 | 51 | 105 | 83 | 10.0% |
| Q1 2019 | 322 | $4.3B | 23,682,537 | 78 | 72 | 87 | 7.4% |
| Q4 2018 | 279 | $2.5B | 23,488,847 | 6 | 5 | 7 | 7.8% |